Investing Profile

Stephen Knight


President and Managing Partner at F-Prime Capital Partners, Massachusetts
Photo of Stephen Knight, Managing Partner at F-Prime Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
F-Prime Capital Partners Managing Partner
$100K - $10.0M
CompanyStageDateRound SizeTotal Raised
Prime Medicine
Series BJul 2021$200M
Series AOct 2019$120M
Co-investors: Robert Nelsen (ARCH Venture Partners), Neil Sirni (Arrive), David Schenkein (GV)
Leyden Labs
Series AMar 2021€40M
Co-investors: Brook Byers (Kleiner Perkins), David Schenkein (GV)
Venture RoundMar 2021$30M
Series BDec 2018€8M
Co-investors: Jim Tananbaum (Foresite Capital)
Series AFeb 2021$70M
Co-investors: Kush Parmar (5am Ventures)
Atalanta Therapeutics
Series AJan 2021$110M
Co-investors: Jessica Alston (F-Prime Capital Partners), Stacie Weninger (F-Prime Capital Partners)
Blueprint Medicines
Series BJan 2014$25M
Series AApr 2011$40M
Co-investors: Thilo Schroeder (Nextech Invest), Daniel Lynch (GV)